Logo image of AKAN

AKANDA CORP (AKAN) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:AKAN - CA00971M5028 - Common Stock

1.5 USD
+0.15 (+11.11%)
Last: 1/23/2026, 8:00:00 PM
1.52 USD
+0.02 (+1.33%)
After Hours: 1/23/2026, 8:00:00 PM

AKAN Key Statistics, Chart & Performance

Key Statistics
Market Cap1.09M
Revenue(TTM)836.70K
Net Income(TTM)-4.10M
Shares730.00K
Float720.00K
52 Week High9.29
52 Week Low0.42
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-12.28
PEN/A
Fwd PEN/A
Earnings (Next)12-13
IPO2022-03-15
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
AKAN short term performance overview.The bars show the price performance of AKAN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 -50 100 150 200

AKAN long term performance overview.The bars show the price performance of AKAN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of AKAN is 1.5 USD. In the past month the price increased by 166.57%. In the past year, price decreased by -70.91%.

AKANDA CORP / AKAN Daily stock chart

AKAN Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to AKAN. When comparing the yearly performance of all stocks, AKAN is a bad performer in the overall market: 95.02% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

AKAN Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to AKAN. AKAN has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AKAN Financial Highlights

Over the last trailing twelve months AKAN reported a non-GAAP Earnings per Share(EPS) of -12.28. The EPS increased by 99.31% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -51.76%
ROE -95.78%
Debt/Equity 0.08
Chartmill High Growth Momentum
EPS Q2Q%99.31%
Sales Q2Q%97.47%
EPS 1Y (TTM)99.31%
Revenue 1Y (TTM)-61.27%

AKAN Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

AKAN Ownership

Ownership
Inst Owners0.01%
Ins OwnersN/A
Short Float %21.02%
Short Ratio0.04

AKAN Latest News, Press Relases and Analysis

About AKAN

Company Profile

AKAN logo image Akanda Corp is a GB-based company operating in Pharmaceuticals industry. Akanda Corp. is a United Kingdom-based company, which is focused on the growth of its Canadian farming property in British Columbia. The firm plans to develop tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities.

Company Info

AKANDA CORP

1A, 1B Learoyd Road

New Romney GB

Employees: 5

AKAN Company Website

AKAN Investor Relations

Phone: 442034889514

AKANDA CORP / AKAN FAQ

What does AKAN do?

Akanda Corp is a GB-based company operating in Pharmaceuticals industry. Akanda Corp. is a United Kingdom-based company, which is focused on the growth of its Canadian farming property in British Columbia. The firm plans to develop tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities.


What is the stock price of AKANDA CORP today?

The current stock price of AKAN is 1.5 USD. The price increased by 11.11% in the last trading session.


Does AKANDA CORP pay dividends?

AKAN does not pay a dividend.


How is the ChartMill rating for AKANDA CORP?

AKAN has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


On which exchange is AKAN stock listed?

AKAN stock is listed on the Nasdaq exchange.


What is the GICS sector and industry of AKAN stock?

AKANDA CORP (AKAN) operates in the Health Care sector and the Pharmaceuticals industry.


Can you provide the number of employees for AKANDA CORP?

AKANDA CORP (AKAN) currently has 5 employees.